TCT 2023, October 23-26, 2023, San Francisco, CA

Join CBSET at TCT 2023, which will be held at the Moscone Center, San Francisco, CA, October 23-26, 2023.

CBSET’s CEO, Peter Markham, and Director of Research and Innovation, Rami Tzafriri, will be attending the conference.

Rami Tzafriri, CBSET's Director of Research and Innovation, will be presenting 2 moderated abstracts at this event:

TCT 739: Ultrasound-Enhanced Catheter Directed Thrombolysis in a Porcine Model of Pulmonary Embolism.  Tuesday, Oct. 24, 4:00 PM, Moderated Abstracts Station 6, Emerging Clinical Science & Research, Hall C, Exhibition Level, Moscone South, as part of the session: Studies of Patients with Pulmonary Embolism or Pulmonary Hypertension II (4:00 PM).

Yes: There Is Always Room For Better Stents.  Tuesday, Oct. 24, 4:36 PM, Coronary Spotlight Theater, Hall E, Exhibition Level, Moscone North, as part of the session: Coronary Spotlight 5: Disruptive Stent Technologies (3:30 PM).

TCT 432: Imaging-Based Evaluation and Differentiation of Vessel Preparation Technologies in a Porcine Model of Peripheral Artery Stenosis.  Wednesday, Oct. 25. 11:09 AM, Moderated Abstracts Station 3, Emerging Clinical Science & Research, Hall A, Exhibition Level, Moscone South, as part of the session Peripheral Vascular Intervention Techniques III (11:00 AM).

 

Please contact us to schedule a meeting around TCT 2023 with the researchers and authors behind some of the most advanced preclinical models for peripheral artery disease (PAD) and thrombolysis/thrombectomy in the field.




    Recent scientific papers/presentations related to Mechanical Thrombectomy research:

    Preclinical evaluation of the ANCD thrombectomy device: safety and efficacy in a swine clot mode. Sanchez S, Bailey L, Ducore R, Andersson T, Nogueira R, Cognard C, Ribo M, Villanova H, Rios A, Galve I. Journal of Neuerointerventional Surgery, 2020 Oct;12(10):1008-1013. doi: 10.1136/neurintsurg-2019-015548.

    Swine Clot Model for the Evaluation of Mechanical Thrombectomy Devices. M Naimark. Presented at: Biointerface 2019, Park City, Utah, September 4-6, 2019.

    Preclinical Evaluation of Mechanical Thrombectomy Devices in a Swine Clot Model. L Bailey, AS; M Gilvarry; M Holian; R Tzafriri, PhD, J Keating, DVM, DACVP, E Edelman, MD, PhD, FACC. Poster presented at: Society of Neurointerventional Surgery (SNIS), Boston, USA, July 25-29, 2016.

    Recent CBSET scientific papers & presentations related to novel PAD therapies:

    Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients Abraham R. Tzafriri, Benny Muraj, Fernando Garcia-Polite, Antonio G. Salazar-Martín, Peter Markham, Brett Zani, Anna Spognardi, Mazen Albaghdadi, Steve Alston, Elazer R. Edelman. Biomaterials. 2020 Nov;260:120337.

    Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics. Abraham R.Tzafriri, Sahil A.Parikh, Elazer R.Edelman. Journal of Controlled Release. Volume 310, 28 September 2019, Pages 94-102.

    Enhanced Plaque Modification of Cadaveric Human Calcified Peripheral Arteries Treated with a Vessel Preparation System. Video interview at CRT19. CBSET’s Director of Research and Innovation, Rami Tzafriri, PhD, discusses CBSET’s human cadaver model assessment of a vessel preparation system and the attributes of this particular technology that suggest it might be conducive to enhancing drug absorption.

    Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis. Abraham R. Tzafriri, Fernando Garcia-Polite, Brett Zani, James Stanley, Benny Muraj, Jennifer Knutson, Robert Kohler, Peter Markham, Alexander Nikanorov, Elazer R. Edelman,  Journal of Controlled Release, Volume 264, 28 October 2017, Pages 203-210.

    charingcrosscoatedballoonsEvaluation of a novel paclitaxel coated intravascular balloon. Abraham R. Tzafriri, PhD. Presented at CX 2017 – The Charing Cross International Symposium, April 25-28, Kensington, London, UK.

     

    Mechanisms Underlying Drug Delivery to Peripheral Arteries. Li J, Tzafriri R, Patel SM, Parikh SA. Interventional Cardiology Clinics. 2017 Apr;6(2):197-216. doi: 10.1016/j.iccl.2016.12.004.

    Two Blades-Up Runs Using the JetStream Navitus Atherectomy Device Achieve Optimal Tissue Debulking of Nonocclusive In-Stent Restenosis: Observations From a Porcine Stent/Balloon Injury Model. Shammas NW, Aasen N, Bailey L, Budrewicz J, Farago T, Jarvis G. Journal of Endovascular Therapy. 2015 Aug;22(4):518-24.

    Effects of Orbital Atherectomy Treatment on Drug Absorption in Calcified Peripheral Arteries. Elazer R. Edelman, MD. Presented at CRT15 – Cardiovascular Research Technologies (CRT); 2015 Feb 21-24; Washington, DC.

    Mechanisms of Tissue Uptake and Retention in Zotarolimus-Coated Balloon Therapy. Vijaya B. Kolachalama, Stephen D. Pacetti, Joseph W. Franses, John J. Stankus, Hugh Q. Zhao, Tarek Shazly, Alexander Nikanorov, Lewis B. Schwartz, Abraham R. Tzafriri, Elazer R. Edelman. Circulation. 2013;127:2047-2055.

    Correlative evaluation of variable pressure-scanning electron microscopy to histology methods for vascular tissues. P. Seifert, K. Regan, B.G. Zani, G. Wong, and J. Stanley. Journal of Histotechnology, 2013 March; 36 (1): 25-29.